Cutaneous sensory nerve endings

Cutaneous sensory nerve endings are the distal terminations of primary afferent neurons located within the dermis and epidermis, serving as the primary interface for transducing environmental stimuli into neural signals (StatPearls, 2023). These endings are equipped with a diverse array of molecular sensors, including voltage-gated sodium channels and transient receptor potential (TRP) channels, which detect mechanical, thermal, and chemical changes (Nature Reviews Neuroscience, 2013). In clinical practice, these endings are the primary site of action for topical analgesics and anesthetics, which aim to modulate pain and itch signals at their source to minimize systemic side effects (British Journal of Anaesthesia, 2007). Pathological alterations in these endings, such as peripheral sensitization or reduced intraepidermal nerve fiber density, are hallmark features of conditions like small fiber neuropathy and chronic pruritus (Journal of Investigative Dermatology, 2012). While not a single molecular target, they represent a critical anatomical compartment for localized drug delivery in pain management and dermatology.

Other names

Dermal nerve endingsPeripheral sensory terminalsSkin sensory receptorsCutaneous afferent terminalsIntraepidermal nerve fibers

Drugs targeting these endings primarily work by blocking voltage-gated sodium channels (e.g., Nav1.7, Nav1.8) to inhibit action potential propagation (British Journal of Anaesthesia, 2007). Other mechanisms include the prolonged activation and subsequent desensitization of TRPV1 channels, leading to a temporary loss of sensory function, or the activation of TRPM8 channels to induce cooling sensations (Nature Reviews Neuroscience, 2013). Additionally, certain toxins inhibit the vesicular release of neurotransmitters like glutamate and substance P from the terminal (StatPearls, 2023).